Product Wiki · Recalls · U.S. FDA — Device Enforcement

Recall Z-2994-2018 — Diagnostica Stago STA N¿oplastine¿ CI, 10 ml vial. In-Vitro Diagnostic for determination of the prothrombin time (PT) in plasma. REF: 00666 The STA¿ - N¿oplastine¿ CI kits provide reagents for the determination of the prothrombin time (PT) in plasma with STA-R¿, STA Compact¿ and STA Satellite¿.

U.S. FDA — Device Enforcement · United States · 2018-07-24 · Class II

AI-assisted, human-edited — this page is drafted with AI from public-source data, then reviewed before publication. How we use AI →

Agency: U.S. FDA — Device Enforcement
Recall identifier: Z-2994-2018
Date of alert: 2018-07-24
Country / jurisdiction: United States
Risk level: Class II
Risk type: recall
Brand: Diagnostica Stago, Inc.
Product category: device
Product type: Devices
Barcode (EAN/GTIN): 03607450006667

Reported risk: QC values outside of the assigned ranges (prolonged Prothrombin time / decreased PT %)

Primary source: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts

Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.

ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.

Related